[HTML] nejm.org

[HTML][HTML] Roxadustat for anemia in patients with kidney disease not receiving dialysis

N Chen, C Hao, X Peng, H Lin, A Yin… - … England Journal of …, 2019 - Mass Medical Soc
Abstract Background Roxadustat (FG-4592) is an oral inhibitor of hypoxia-inducible factor
(HIF) prolyl hydroxylase that stimulates erythropoiesis and regulates iron metabolism. In …
被引用次数：540 相关文章

Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis.

N Chen, C Hao, X Peng, H Lin, A Yin, L Hao… - The New England …, 2019 - europepmc.org
Background Roxadustat (FG-4592) is an oral inhibitor of hypoxia-inducible factor (HIF) prolyl
hydroxylase that stimulates erythropoiesis and regulates iron metabolism. In phase 2 studies …

Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis

N Chen, C Hao, X Peng, H Lin, A Yin… - The New England …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Roxadustat (FG-4592) is an oral inhibitor of hypoxia-inducible factor (HIF) prolyl
hydroxylase that stimulates erythropoiesis and regulates iron metabolism. In phase 2 studies …

[引用][C] Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis

N Chen, C Hao, X Peng, H Lin, A Yin, L Hao… - New England Journal …, 2019 - cir.nii.ac.jp
Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
[HTML] mpg.es

[HTML][HTML] Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis

N Chen, C Hao, X Peng, H Lin, A Yin… - … England Journal of …, 2019 - mpgjournal.mpg.es
Background Roxadustat (FG-4592) is an oral inhibitor of hypoxia-inducible factor (HIF) prolyl
hydroxylase that stimulates erythropoiesis and regulates iron metabolism. In phase 2 studies …